v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 17,778 $ 0 $ 21,382 $ 0
Operating expenses:        
Cost of goods sold 192 0 285 0
Research and development 106,102 101,950 306,967 320,873
Selling, general and administrative 37,485 35,484 107,279 97,104
Intangible asset amortization 750 0 1,500 0
Total operating expenses 144,529 137,434 416,031 417,977
Loss from operations (126,751) (137,434) (394,649) (417,977)
Other income:        
Gain on sale of priority review voucher, net 194,000 0 194,000 0
Interest and other income, net 2,877 10,532 14,775 33,986
Total other income 196,877 10,532 208,775 33,986
Total other income 70,126 (126,902) (185,874) (383,991)
Other comprehensive income (loss):        
Net unrealized gain (loss) on marketable securities, net of tax (4,390) 162 (7,041) (919)
Comprehensive income (loss) $ 65,736 $ (126,740) $ (192,915) $ (384,910)
Net income (loss) per share:        
Net income (loss) per share, basic (usd per share) $ 0.37 $ (0.74) $ (0.99) $ (2.24)
Net income (loss) per share, diluted (usd per share) $ 0.37 $ (0.74) $ (0.99) $ (2.24)
Weighted-average shares used in calculating net income (loss) per share:        
Weighted average number of shares outstanding, basic (in shares) 188,387,660 172,421,492 187,452,793 171,702,183
Weighted average number of shares outstanding, diluted (in shares) 192,077,855 172,421,492 187,452,793 171,702,183